Search Within

Parastoo Bahrami Dahi

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Meeting Abstract (21)
  2. Journal Article (13)
  3. Research Letter (1)
Groups
  1. Bone Marrow Transplant (35)
  2. CTCR Scholars (35)
  3. Center for Hematologic Malignancies (35)
  4. Department of Medicine (35)
  5. Department of Pathology and Laboratory Medicine (35)
  6. Hematologic Malignancies, Division of (35)

More Groups

People
  1. Sergio Giralt (26)
  2. Gunjan Shah (25)
  3. Sean Devlin (20)
  4. Miguel-Angel Perales (19)
  5. Craig Sauter (18)
  6. Michael Scordo (17)

More People

Years
  1. 2024 (1)
  2. 2023 (5)
  3. 2022 (7)
  4. 2021 (1)
  5. 2020 (11)
  6. 2019 (3)

More Years

Publications
  1. Blood (10)
  2. Biology of Blood and Marrow Transplantation (8)
  3. Transplantation and Cellular Therapy (5)
  4. Journal of Clinical Investigation (3)
  5. Bone Marrow Transplantation (2)
  6. Clinical Lymphoma, Myeloma and Leukemia (2)

More Publications

Publishers
  1. Elsevier Inc. (15)
  2. American Society of Hematology (11)
  3. Nature Publishing Group (4)
  4. American Society for Clinical Investigation (3)
  5. Adis International Ltd (1)
  6. Taylor & Francis Group (1)

Results (35)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pharmacokinetics and toxicities after Evomela® (propylene glycol free melphalan) with hematopoietic stem cell transplant (HCT) for multiple myeloma (MM), AL amyloidosis (AL), lymphoma, acute myeloid leukemia (AML), and myelodysplastic syndrome (MDS)
    Meeting Abstract

    Shah, G. L.; Landau, H.; Sarubbi, C.; Schofield, R.; Lin, A.; Bhatt, V.; Harnicar, S.; Devlin, S. M.; Castro-Malaspina, H.; Chung, D. J.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Feasibility, tolerability, and patient-reported outcomes with pharmacokinetic (PK)-directed dosing of Evomela (propylene glycol free melphalan) for multiple myeloma and AL amyloidosis patients undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S. J.; Hoover, E.; Chung, D. J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Pharmacokinetics and toxicities after Evomela® (propylene glycol free melphalan) with autologous hematopoietic stem cell transplant (AHCT) for multiple myeloma and AL amyloidosis
    Meeting Abstract

    Shah, G. L.; Landau, H.; Sarubbi, C.; Schofield, R.; Lin, A.; Bhatt, V.; Harnicar, S. J.; Devlin, S. M.; Chung, D. J.; Dahi, P. B.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • A phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory B-and T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M. A.; Lynch, P.; Scheuerman, M.; Minnal, V.; Galasso, N.; Kumar, A.; Gerecitano, J.; Zelenetz, A. D.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • A Phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M.; Lynch, P.; Scheuerman, M.; Kumar, A.; Gerecitano, J. F.; Zelenetz, A. D.; Hamlin, P. A. Jr; Noy, A.; more...
    Blood (2016)

    Fulltext@MSK | Save